AcouSort
8,86
SEK
+13,59 %
ACOU
First North Stockholm
Medical Equipment & Services
Health Care
Mindre end 1K følgere
+13,59%
-15,22%
-19,45%
-31,58%
-45,31%
-36,71%
-62,69%
-4,41%
+12,28%
AcouSort is active within medical technology. The company conducts research and development in a proprietary platform technology that utilises ultrasound to separate and analyse composition of biological cells. The technology is mainly used in the analysis of various cases of cancer as well as sepsis. Part of the research is done together with other stakeholders within field. The company was founded in 2010 and is based in Lund.
Læs mereMarkedsværdi
132,32 mio. SEK
Aktieomsætning
267,11 t SEK
Omsætning
4,74 mio.
EBIT %
-340,43 %
P/E
-
Udbytteafkast, %
-
Finanskalender
28.5
2025
Delårsrapport Q1'25
18.6
2025
Generalforsamling '25
27.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
AcouSort reschedules the 2024 year-end report to February 14, 2025
AcouSort to meet with leading cell therapy and flow cytometry companies at two upcoming conferences
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools